November 29, 2016 - By Michael Collier
In analysts report shared with investors and clients on Tuesday morning, Byotrol PLC (LON:BYOT) stock “Corporate” was restate at finnCap. They currently have a GBX 6.90 target price on the stock. finnCap’s target price means a potential upside of 45.26% from the company’s last price.
Byotrol Plc (LON:BYOT) has risen 22.58% since April 28, 2016 and is uptrending. It has outperformed by 17.32% the S&P500.
Byotrol plc is engaged in the development, patenting, licensing and sale of anti- microbial products and technologies for business and consumer use. The company has a market cap of 12.46 million GBP. The Firm makes products based on anti-microbial technology in the United Kingdom. It currently has negative earnings. The Company’s divisions include Professional , Consumer and Pet.
More news for Byotrol Plc (LON:BYOT) were recently published by: Uk.Finance.Yahoo.com, which released: “PEG Ratio (5 yr expected):” on July 04, 2011. Theguardian.com‘s article titled: “NHS funding is falling behind European neighbours’ average, research finds” and published on January 20, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.